Financial Performance - The total operating revenue for 2025 reached CNY 550,074.55 million, representing a year-on-year increase of 10.94%[2] - The net profit attributable to shareholders of the parent company was CNY -196,891.19 million, an improvement of 21.81% compared to the previous year[5] - The net profit attributable to shareholders of the parent company, after deducting non-recurring gains and losses, was CNY -204,758.65 million, improving by 20.83% year-on-year[5] - The basic earnings per share were CNY -0.14, compared to CNY -0.18 in the previous year[2] - The weighted average return on net assets improved to -21.76%, an increase of 0.53 percentage points from the previous year[2] Assets and Equity - Total assets at the end of the reporting period were CNY 2,679,408.43 million, a decrease of 9.46% from the beginning of the period[3] - Shareholders' equity attributable to the parent company was CNY 806,518.78 million, down 19.62% from the beginning of the period[3] Operational Improvements - The company implemented measures to enhance quality management, optimize the supply chain, and control financial costs, contributing to improved gross profit margin and net profit[7] - The cash flow from operating activities turned positive, indicating a continuous improvement in overall operational performance[7] Audit and Reporting - The financial data presented are preliminary and subject to final audit, with potential discrepancies in the annual report[9]

Financial Performance Forecast - The company expects a net profit attributable to shareholders of the parent company for 2025 to be between 21 million and 30 million yuan, an increase of 55.5 million to 64.5 million yuan compared to the previous year [3]. - The net profit attributable to shareholders after deducting non-recurring gains and losses is projected to be between 5 million and 7.5 million yuan, an increase of 56.5 million to 58.9 million yuan year-over-year [3]. - The previous year's net profit attributable to shareholders was a loss of 34.5 million yuan, with a total profit of -5.33 million yuan [4]. Factors Influencing Financial Performance - The company has improved its financial performance due to increased product acceptance and effective cost control in sales, management, and R&D expenses [5]. - There were no significant impairment losses on equity investments in the current reporting period, unlike the previous year [5]. Earnings Forecast and Risks - The company has not identified any major uncertainties that could significantly affect the accuracy of this earnings forecast [6]. - The earnings forecast is based on preliminary calculations and has not yet been audited by certified public accountants [6]. - Investors are advised to pay attention to investment risks as the data provided is preliminary and subject to change upon the release of the audited annual report [7].

Financial Projections - The company expects to achieve operating revenue of between 670 million and 700 million yuan in 2025, representing a year-on-year growth of 41.18% to 47.50%[3] - The net profit attributable to the parent company is projected to be between -26 million and -18 million yuan, indicating continued losses compared to the previous year[3] - The net profit attributable to the parent company, after deducting non-recurring gains and losses, is expected to be between -30 million and -22 million yuan[3] - In the previous year, the operating revenue was 474.585 million yuan, with a net profit of -1.974 million yuan[5] - The performance forecast is based on preliminary calculations by the finance department and has not been audited by a registered accountant[10] - Investors are advised to be cautious as the forecast data is preliminary and the final audited financial data will be disclosed in the 2025 annual report[11] Cost and Profitability Factors - The increase in costs during the capacity ramp-up phase is a significant factor affecting profitability, driven by high labor and depreciation costs[8] - The increase in revenue has led to a rise in accounts receivable, resulting in higher credit impairment losses compared to the previous year[9] Market Focus and Development - The company plans to focus on markets such as AI high-speed connectors, optical modules, and automotive electronics, while accelerating overseas market expansion[9] - The company aims to enhance its online platform www.wantpcb.com to improve PCB prototyping experiences and achieve differentiated development[9]

Financial Performance - The company expects a net profit loss between 58 million and 83 million yuan for the fiscal year 2025, compared to a loss of 66.62 million yuan in the same period last year [4]. - Revenue is projected to be between 1.01 billion and 1.061 billion yuan, reflecting a year-on-year change of -2% to 3% from 1.0309264 billion yuan [4]. - The impact of non-recurring gains and losses on net profit is estimated to be approximately 8.7 million yuan, down from 10.06 million yuan in the previous year [6]. Market Conditions - The company faces increased competition in its industry, leading to a contraction in gross profit margins for some products [6]. - The benefits from the application expansion of new products have not yet been fully realized, contributing to the overall performance pressure [6]. Audit and Reporting - The financial data in the earnings forecast has not been audited by the accounting firm, and the company has communicated with them regarding the forecast without major discrepancies [5]. - The specific financial data will be detailed in the company's 2025 annual report, urging investors to make cautious decisions and be aware of investment risks [7].

Financial Projections - The estimated net profit for 2025 is projected to be between -3 million and -2 million CNY, a significant decrease compared to the previous year's profit of 14.77 million CNY[5] - The net profit after deducting non-recurring gains and losses is expected to be between -8 million and -7 million CNY, showing an increase compared to the previous year's loss of 15.68 million CNY[5] - The decrease in net profit is primarily due to a significant reduction in non-recurring gains and losses, estimated to be around 5 million CNY for 2025[7] Market Outlook - The company anticipates increased demand in the vehicle emission testing equipment market due to stricter regulatory requirements from the Ministry of Ecology and Environment[8] - The change in the scope of consolidation due to the acquisition of a subsidiary is also a contributing factor to the expected financial performance[8] Financial Reporting - The financial data in this earnings forecast has not been audited by a registered accounting firm[6] - The specific financial data for the 2025 fiscal year will be detailed in the company's annual report[9] - The company emphasizes the importance of timely information disclosure in accordance with relevant laws and regulations[9] Investor Guidance - Investors are advised to make cautious decisions and be aware of investment risks[9] - The earnings forecast period is from January 1, 2025, to December 31, 2025[3]

2025 年度业绩预告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记载、误导性陈述或者重 大遗漏。 一、本期业绩预计情况 1.业绩预告期间：2025 年 1 月 1 日-2025 年 12 月 31 日 证券代码：000026 200026 证券简称：飞亚达 飞亚达 B 公告编号：2026-003 飞亚达精密科技股份有限公司 2.业绩预告情况：预计净利润为正值且属于同向下降情形 | 项目 | 本报告期 | | | 上年同期 | | | | --- | --- | --- | --- | --- | --- | --- | | 归属于上市公司股 东的净利润 | 盈利：7,600 | 万元–9,800 | 万元 | 盈利：22,035.02 | 万元 | | | | 比上年同期下降：65.51%-55.53% | | | | | | | 扣除非经常性损 益后的净利润 | 盈利：7,200 | 万元–9,400 | 万元 | 盈利：20,872.83 | 万元 | | | | 比上年同期下降：65.51%-54.97% | | | | | | | 基本每股收益 | 盈利：0.1873 | 元 ...

Financial Performance - The company expects a net loss of between 170 million and 240 million yuan for the fiscal year 2025, compared to a loss of 156.30 million yuan in the same period last year[3] - The net loss after deducting non-recurring gains and losses is projected to be between 177.50 million and 247.50 million yuan, compared to a loss of 199.54 million yuan in the previous year[3] - The company anticipates a reduction of approximately 35.73 million yuan in non-recurring gains and losses, primarily due to a significant decrease in government subsidies[6] Investment and Development - The primary reason for the loss is the ongoing investment in innovative drug development, with significant R&D and management expenses due to prior fixed asset investments[5] - The clinical trial for the innovative hepatitis B treatment drug GST-HG141 has enrolled 526 participants, meeting the planned target, with full enrollment expected by mid-February 2026[5] Asset Management - The company is conducting impairment tests on intangible assets, inventory, and fixed assets, with provisions for impairment being made[6] Caution for Investors - The final financial data for the fiscal year 2025 will be disclosed in the annual report, and investors are advised to exercise caution[7]

Financial Projections - The company expects a net profit in the range of -50,000 to -25,000 thousand yuan for the year 2025, representing a decrease of 6.29% to an increase of 46.86% compared to the previous year[5]. - The net profit attributable to shareholders after deducting non-recurring gains and losses is projected to be between -56,000 and -28,000 thousand yuan, reflecting a decrease of 21.17% to an increase of 39.41% year-over-year[5]. - The basic earnings per share is estimated to be between -0.2901 and -0.1451 yuan, compared to -0.2685 yuan in the previous year[5]. Operational Challenges - The decline in operating income and gross profit is attributed to intensified market competition and extended project settlement cycles[7]. Impairment and Tax Assets - The company plans to recognize impairment losses on accounts receivable, contract assets, and long-term receivables, with specific amounts pending audit confirmation[8]. - The company has terminated the recognition of certain deferred tax assets based on the principle of prudence[8]. Financial Reporting - The financial data presented is preliminary and subject to final confirmation in the 2025 annual report, highlighting investment risks[10].

证券代码：002068 证券简称：黑猫股份 公告编号：2026-001 江西黑猫炭黑股份有限公司 2025年度业绩预告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 一、本期业绩预计情况 1、业绩预告期间：2025年1月1日至2025年12月31日 二、与会计师事务所沟通情况 本次业绩预告未经会计师事务所预审计。公司已就本次业绩预告与年报审计会计 师事务所进行了预沟通，公司与会计师事务所在业绩预告方面不存在分歧。 三、业绩变动原因说明 报告期内，公司主要产品受行业多重因素叠加影响，主要原料煤焦油价格全年波 动剧烈且整体承压，成本端压力持续凸显；叠加下游轮胎行业影响，炭黑市场需求支 撑不足，行业供需格局承压，产品价格与成本出现倒挂，导致公司主要产品利润空间 被大幅挤压，盈利水平下滑。后续公司将着力强化科技创新驱动，深化成本管控与生 产运营效率提升，修复整体毛利，稳步改善经营状况。 四、其他相关说明 本次业绩预告是公司财务部门初步测算的结果，未经会计师事务所审计，具体财 务数据将在公司2025年度报告中详细披露，敬请广大投资者注意投资风险。 证券代码：00206 ...

证券代码：002975 证券简称：博杰股份 公告编号：2026-014 珠海博杰电子股份有限公司 2025 年度业绩预告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 一、本期业绩预计情况 1、业绩预告期间：2025 年 1 月 1 日至 2025 年 12 月 31 日。 单位：万元 | 项 目 | 本会计年度 | | | | 上年同期 | | --- | --- | --- | --- | --- | --- | | 归属于上市公司股东的净利润 | 13,000.00 | | ～ | 16,000.00 | 2,225.42 | | | 比上年同期增长 | 484.16% | ～ | 618.97% | | | 扣除非经常性损益后的净利润 | | 8,000.00 | ～ | 11,000.00 | 894.37 | | | 比上年同期增长 | 794.48% | ～ | 1,129.92% | | | 基本每股收益（元/股） | | 0.85 | ～ | 1.05 | 0.16 | | 营业收入 | | 170,000.00 | ～ | 195,000 ...